
Kening Biotech
科凝生物
Kening Biotech
Biotech/Healthcare
Koning Biotech is an innovative drug developer focused on creating drugs based on advanced drug delivery systems. The company uses multidisciplinary technologies and a multi-platform strategy to control drug release in both time and space.
Latest round: Pre Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.